ANSV
Anesiva

Last release date: August 7, 2008

Anesiva's Good Adlea Results [Demember 16, 2008]
Anesiva (ANSV) Drops Zingo [November 11, 2008]
Anesiva Goes Commercial [October 23, 2007]
Anesiva Zingo Approved by FDA [August 17, 2007]

Analyst Conference Summaries Available:

2008
Anesiva Q2 2008 summary
Anesiva Q1 analyst conference summary 2008
Anesiva analyst conference summary q4 2007
08/07/2008
05/08/2008
02/11/2008
Q2 2008
Q1 2008
Q4 2007
2007
ANSV analyst conference summary Q3 2007
ANSV summary Q2 2007
ANSV conference summary
Press Release Only
11/01/2007
07/26/2007
05/08/2007
02/08/2007
Q3 2007
Q2 2007
Q1 2007
Q4 2006
2006
ANSV Q3 2006
ANSV Q1 2006
11/09/2006
08/09/2006
05/04/2006
Q3 2006
Q2 2006
Q1 2006

Comment on Anesiva announcement of clinical plans January 8, 2007.

Anesiva is a development-stage biotech pharmaceutical company specializing in products for pain, with Zingo approved by the FDA and Adlea under development. Anesiva was formerly Corgentech.

ANSV Web site:

main page
investor page

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. Before making or terminating an investment you should always verify any factual basis of your decision.